SportHorses.vet is an independent equine veterinary service based in Bocholt (3950), Belgium.
Specialized in equine orthopedics, sport horse medicine and performance-oriented veterinary care across Europe.
In contemporary veterinary medicine for the sport horse, particularly in show jumping horses, autologous biological and cellular therapies represent a fundamental shift in the management of joint inflammation, cartilage degeneration, and high-performance-related injuries.
Unlike purely symptomatic treatments, these approaches use advanced biological mechanisms — many derived from the horse’s own body — to:



Therapies such as IRAP, PRP and Alpha-2-Macroglobulin (A2M) belong to the group of:
These treatments are derived from the horse’s own blood and are designed to intervene in key biological processes involved in:
At a more advanced level, cellular therapies expand the concept of traditional orthobiology toward deeper biological modulation.
IRAP, also known as Autologous Conditioned Serum (ACS), focuses on inhibiting Interleukin-1 (IL-1), a central cytokine in inflammatory and degenerative joint processes.
IRAP does not regenerate tissue. Its goal is to reduce the intra-articular inflammatory cascade, promoting a more stable biological environment for performance.
Platelet-Rich Plasma (PRP) is an autologous platelet concentrate rich in growth factors involved in tissue repair and remodeling.
PRP is indicated when the objective is to stimulate biological repair, particularly in soft tissues exposed to high mechanical stress.
Alpha-2-Macroglobulin (A2M) is a protein capable of inhibiting enzymes responsible for cartilage degradation.
A2M plays a protective and preventive role, especially when the objective is to preserve cartilage integrity before irreversible damage occurs.
Autologous Protein Solution (APS) combines:
APS is indicated in joints with active inflammation where broader biological modulation is required.
Exosome-based and cellular therapies are currently in an emerging phase but generate strong interest in both human and veterinary medicine.
These approaches act through highly specific cellular signaling mechanisms, with potential to modulate inflammation, tissue repair and intercellular communication more precisely than conventional therapies.
These options represent the future of regenerative medicine and must be indicated with clinical judgment, experience, and deep understanding of performance demands — particularly in high-level show jumping horses.
There is no universal solution. Treatment selection must be based on:
| Clinical Situation | Recommended Approach |
|---|---|
| Predominant joint inflammation | IRAP (ACS) |
| Soft tissue injury | PRP |
| Cartilage protection | A2M |
| Complex inflammation | APS |
| Selected advanced cases | Cellular / Exosomal therapies |
In show jumping horses, where joints are subjected to repeated and high mechanical loads, the objective is not merely symptom control, but protection of long-term athletic longevity.
The correct indication of biological and cellular therapies forms part of an advanced veterinary strategy based on precise diagnosis, performance experience, and transparent communication with owners and buyers.
The indication of biological therapies requires accurate diagnosis, high-performance clinical experience, and long-term performance vision.
At Sporthorses.vet, these therapies are integrated into a global veterinary strategy focused on athletic longevity and performance preservation


Equine Orthopedic Veterinarian
Bocholt 3950, Belgium
2023 © All rights reserved.
SportHorses.vet is an independent equine veterinary service based in Bocholt (3950), Belgium.
Specialized in equine orthopedics, sport horse medicine and performance-oriented veterinary care across Europe.